Deadly partnership to bolster First Nations representation in medical research
Posted: 27 May 2022 WEHI has partnered with leading Indigenous not-for-profit, DeadlyScience, to foster the next generation of Aboriginal and Torres Strait Islander scientists, in the first partnership of its kind. At a glance WEHI partners with DeadlyScience to pave the…
EOI: COLLABORATIVE PROJECT PROPOSALS IN MEDICAL COUNTERMEASURES
Posted: 27 May 2022 Closing: 30 June 2022 DMTC SEEKS COLLABORATIVE PROJECT PROPOSALS IN MEDICAL COUNTERMEASURES All information about the EOI process and submission requirements can be found on our website. DMTC is an independent, not-for-profit company that…
Burnet Institute partners with Moderna to develop novel mRNA vaccines
Posted: 26 May 2022 Media Release: 18 May 2022 Burnet Institute is to partner with world-leading mRNA vaccine manufacturer Moderna, through their cutting-edge mRNA Access program, to develop novel mRNA vaccines for a range of emerging and neglected infectious…
Regulation of Cosmetics in Australia
Posted: 24 May 2022 Stephens Lawyers & Consultants Introduction The importation, manufacture, advertising and supply of cosmetics in Australia is highly regulated and complex. Before a cosmetic product or range can be launched in the Australian market –…
AI created Inventions or Works – Are they protected by Australian IP laws?
Posted: 24 May 2022 Katarina Klaric, Principal, Stephens Lawyers & Consultants Artificial intelligence (AI) and automated decision-making technology is being deployed by government and business to automate or improve operational capabilities. AI technology or systems also are increasingly…
VivaZome to collaborate with UQ Traumatic Brain Injury experts to develop exosome-based therapies
Posted: 20 May 2022 19th May 2022; Melbourne, Australia: VivaZome Therapeutics Pty Ltd (VivaZome) today announced that it has entered into a Memorandum of Understanding (MoU) with The University of Queensland (UQ) focussing on improved therapies for Traumatic…
ENA Respiratory Selected for BLUE KNIGHT™ to Accelerate Development of Pan-Antiviral Nasal Spray
Posted: 19 May 2022 Sydney, Australia, 11th May 2022 – ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pan-antiviral prophylaxis in at-risk populations and pandemic preparedness, has been selected to join…
The Power of Meaningful Relationships
Posted: 19 May 2022 The Connecting Women Lunch hosted on Friday 13th May 2022 marked its 12th anniversary. It was an honour to be back this year as a guest and see women celebrated for their achievements within…
$180m redevelopment of St Vincent’s Private Hospital Fitzroy set to begin
Posted: 19 May 2022 Construction set to begin on $180 million St Vincent’s Private Hospital Fitzroy redevelopment St Vincent’s Health Australia will mark the start of construction of its state-of-the-art, $180m Fitzroy private hospital redevelopment with a sod-turning…
Future Skills in Pharmaceutical GMP Supported by Updated Units of Competency
Posted: 9 May 2022 Skills in pharmaceutical good manufacturing practice (GMP) are essential to the Australian pharmaceutical industry, which support the production and distribution of safe and effective pharmaceuticals for the public. The skills for working in Pharmaceutical…
Bionics Institute Excellence in Medical Device Innovation Award – nominations close 13 May
Posted: 6 May 2022 Nominations close: 13 May 2022 Nominations for the Bionics Institute 2022 Award for Excellence in Medical Device Innovation close on Friday 13 May. This accolade recognises an Australian who, through innovation, has made a…
Awards Recognise Women Excellence in Healthtech
Posted: 5 May 2022 The innovation and inspiration of three outstanding women in Victoria’s healthtech industry have been recognised with BioMelbourne Network Women in Leadership Awards. Their work has helped spark industry advancement and inspire others to follow…
